Passive and active immunization against respiratory syncytial virus for the young and old
Introduction: Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in infants worldwide and also causes significant disease in the elderly. Despite 60 years of RSV research and vaccine development, there is only one approved medicine to prevent RSV infections....
Saved in:
Main Authors: | Tonya Villafana (Author), Judith Falloon (Author), M. Pamela Griffin (Author), Qing Zhu (Author), Mark T. Esser (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current strategies and perspectives for active and passive immunization against Respiratory Syncytial Virus in childhood
by: Marcelo Comerlato Scotta, et al.
Published: (2023) -
Generalized ROC methods for immunogenicity data analysis of vaccine phase I studies in a seropositive population
by: Li Yu, et al.
Published: (2018) -
The Burden of Respiratory Syncytial Virus Infection in the Young
Published: (2019) -
Respiratory syncytial virus infection and the need for immunization in Korea
by: Hye Young Kim, et al.
Published: (2023) -
Respiratory syncytial virus mortality among young children
by: Geoffrey A Weinberg
Published: (2017)